Is there an acceptable ceiling for bleeding for an antithrombotic drug dose to be tested in a phase 3 trial?
White
Harvey D
HD
Department of Cardiology, Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92 189, Auckland 1030, New Zealand. harveyw@adhb.govt.nz